Article
TRPV1 variants impair intracellular Ca2+ signaling and may confer susceptibility to malignant hyperthermia.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Feb 2019
Vanden Abeele Fabien, Lotteau Sabine, Ducreux Sylvie, Dubois Charlotte, Monnier Nicole, Hanna Amy, Gkika Dimitra, Romestaing Caroline, Noyer Lucile, Flourakis Matthieu, Tessier Nolwenn, Al-Mawla Ribal, Chouabe Christophe, Lefai Etienne, Lunardi Joël, Hamilton Susan, Fauré Julien, Van Coppenolle Fabien, Prevarskaya Natalia
Abstract excerpt
PURPOSE: Malignant hyperthermia (MH) is a pharmacogenetic disorder arising from uncontrolled muscle calcium release due to an abnormality in the sarcoplasmic reticulum (SR) calcium-release mechanism triggered by halogenated inhalational anesthetics. However, the molecular mechanisms involved are still incomplete. METHODS: We aimed to identify transient receptor potential vanilloid 1 (TRPV1) variants within the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
